IKESTRO Trademark

Trademark Overview

On Monday, October 23, 2017, a trademark application was filed for IKESTRO with the United States Patent and Trademark Office. The USPTO has given the IKESTRO trademark a serial number of 87655611. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 31, 2021. This trademark is owned by JOHNSON & JOHNSON. The IKESTRO trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for treatment of inflammatory diseases, oncological, cardiovascular, central nervous system and auto-immune diseases
ikestro

General Information

Serial Number87655611
Word MarkIKESTRO
Filing DateMonday, October 23, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 31, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2018

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for treatment of inflammatory diseases, oncological, cardiovascular, central nervous system and auto-immune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 1, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Tuesday, June 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 31, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 23, 2020EXTENSION 5 GRANTED
Friday, September 18, 2020EXTENSION 5 FILED
Friday, September 18, 2020TEAS EXTENSION RECEIVED
Saturday, April 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 2, 2020EXTENSION 4 GRANTED
Thursday, April 2, 2020EXTENSION 4 FILED
Thursday, April 2, 2020TEAS EXTENSION RECEIVED
Wednesday, October 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2019EXTENSION 3 GRANTED
Monday, October 21, 2019EXTENSION 3 FILED
Monday, October 21, 2019TEAS EXTENSION RECEIVED
Tuesday, April 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 12, 2019EXTENSION 2 GRANTED
Friday, April 12, 2019EXTENSION 2 FILED
Friday, April 12, 2019TEAS EXTENSION RECEIVED
Wednesday, January 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 29, 2019EXTENSION 1 GRANTED
Wednesday, October 24, 2018EXTENSION 1 FILED
Friday, January 25, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 16, 2018NOTICE OF REVIVAL - E-MAILED
Friday, November 16, 2018EXTENSION RECEIVED WITH TEAS PETITION
Friday, November 16, 2018PETITION TO REVIVE-GRANTED
Friday, November 16, 2018TEAS PETITION TO REVIVE RECEIVED
Tuesday, April 24, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 24, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 23, 2018ASSIGNED TO EXAMINER
Wednesday, November 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 26, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

ikestro diseases central nervous system immune auto cardiovascular oncological pharmaceutical preparations